Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia
暂无分享,去创建一个
M. Tschan | M. Fey | A. Tobler | B. Borisch | F. Rassool | S. Ong | U. Peters | U. Hasse | E. Oppliger
[1] M. L. Le Beau,et al. An FHIT tumor suppressor gene? , 1998, Genes, chromosomes & cancer.
[2] F. Kaye,et al. Protein expression and functional analysis of the FHIT gene in human tumor cells. , 1998, Journal of the National Cancer Institute.
[3] L. Mao. Tumor suppressor genes: does FHIT fit? , 1998, Journal of the National Cancer Institute.
[4] David I. Smith,et al. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact , 1998, Oncogene.
[5] C. Croce,et al. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[6] L. D. Barnes,et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Chang,et al. Aberrant FHIT transcripts in acute myeloid leukaemia , 1997, British journal of haematology.
[8] M. Fey,et al. Comparative detection and quantitation of human CDK inhibitor mRNA expression of p15INK4B, p16INK4A, p16β, p18INK4C, p19INK4D, p21WAF1, p27KIP1 and p57KIP2 by RT‐PCR using a polycompetitive internal standard , 1997, British journal of haematology.
[9] Stanley N Cohen,et al. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours , 1997, Oncogene.
[10] C. Lima,et al. Structure-based analysis of catalysis and substrate definition in the HIT protein family. , 1997, Science.
[11] D. Beer,et al. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas , 1997, Oncogene.
[12] J. Minna,et al. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines , 1997, Genes, chromosomes & cancer.
[13] A. Feinberg,et al. Aberrant splicing but not mutations of TSG101 in human breast cancer. , 1997, Cancer research.
[14] S. Naylor,et al. Normal FHIT transcripts in renal cell cancer‐ and lung cancer‐derived cell lines, including a cell line with a homozygous deletion in the FRA3B region , 1997, Genes, chromosomes & cancer.
[15] F. Mitelman,et al. Variable FHIT transcripts in non‐neoplastic tissues , 1997 .
[16] M. Kurosumi,et al. Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. , 1997, Cancer research.
[17] K. Miyagawa,et al. Decreased or Altered Expression of the FHIT Gene in Human Leukemias , 1997, Stem cells.
[18] B. Johansson,et al. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia , 1997, Nature Genetics.
[19] C. Croce,et al. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. , 1997, Cancer research.
[20] R. Lotan,et al. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. , 1996, Cancer research.
[21] L. D. Barnes,et al. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase. , 1996, Biochemistry.
[22] C. Croce,et al. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. , 1996, Cancer research.
[23] R. Espinosa,et al. Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2. , 1996, Genomics.
[24] B. Dewald,et al. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin , 1996, The Journal of experimental medicine.
[25] C. Croce,et al. The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer , 1996, Cell.
[26] C. Croce,et al. The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.
[27] Y. Sanchez,et al. A tumor suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Naylor,et al. Definition of a tumor suppressor locus within human chromosome 3p21-p22. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[29] H. Brauch,et al. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma , 1988, Nature.
[30] J. Minna,et al. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. , 1987, The New England journal of medicine.
[31] J. Yunis,et al. Constitutive fragile sites and cancer. , 1984, Science.
[32] J. Rowley,et al. Cancer biology: Heritable fragile sites in cancer , 1984, Nature.
[33] J. Stephenson,et al. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.